The global Mycoplasma Testing Market is experiencing strong growth driven by rising biopharmaceutical production, increasing contamination risks in cell culture, and expanding regulatory scrutiny. Advancements in rapid PCR-based detection technologies are reshaping the Mycoplasma Testing Market.  According to industry analysis, the market is projected to grow from US$ 1.18 billion in 2025...